CVS Health Reports New Director Election
Summary
CVS Health Corporation's Board of Directors elected John E. Gallina to serve on the Board, effective March 19, 2026, following the election on March 18, 2026. Mr. Gallina was also appointed to the Audit Committee and designated an "audit committee financial expert" under relevant SEC rules. He is the former Executive Vice President and Chief Financial Officer of Elevance Health, Inc., where he served for nearly 30 years in various finance and audit-related roles. His compensation for service will be consistent with other non-employee directors, subject to proration.
Why It Matters
The election of John E. Gallina, a former CFO and designated "audit committee financial expert," strengthens CVS Health's Board and its Audit Committee. His extensive background in finance and audit from a leading health benefits provider brings valuable expertise to the company's corporate governance.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how CVS traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View CVS Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Key Quote
“On March 18, 2026, the Board of Directors (the "Board") of CVS Health Corporation ("CVS Health" or the "Company") elected John E. Gallina to serve on the Board, effective March 19, 2026.”
— From Item 5.02
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000064803
- Filing Date
- Thursday, March 19, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- positive